Cargando…

New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action

BACKGROUND: Chuankezhi (CKZ) injection is a traditional Chinese medicine (TCM) injection extracted from Chinese herbs Epimedium sagittatum (Yin Yang Huo) and Morinda officinalis (Bai Ji Tian). Studies have shown that CKZ has a positive effect on improving diabetic nephropathy and regulating immune f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Rui, Yang, Xiang-Na, Lin, Shan, Yi, Wei-Qing, Chen, Xiao-Gang, Dong, Xin, Guo, Long-Gang, Li, Yan-Kun, Zhao, Yue-Rui, Xu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263774/
https://www.ncbi.nlm.nih.gov/pubmed/35813313
http://dx.doi.org/10.21037/atm-22-1962
_version_ 1784742820410556416
author Liang, Rui
Yang, Xiang-Na
Lin, Shan
Yi, Wei-Qing
Chen, Xiao-Gang
Dong, Xin
Guo, Long-Gang
Li, Yan-Kun
Zhao, Yue-Rui
Xu, Hua
author_facet Liang, Rui
Yang, Xiang-Na
Lin, Shan
Yi, Wei-Qing
Chen, Xiao-Gang
Dong, Xin
Guo, Long-Gang
Li, Yan-Kun
Zhao, Yue-Rui
Xu, Hua
author_sort Liang, Rui
collection PubMed
description BACKGROUND: Chuankezhi (CKZ) injection is a traditional Chinese medicine (TCM) injection extracted from Chinese herbs Epimedium sagittatum (Yin Yang Huo) and Morinda officinalis (Bai Ji Tian). Studies have shown that CKZ has a positive effect on improving diabetic nephropathy and regulating immune function. Focal segmental glomerulosclerosis (FSGS) is a kind of refractory nephropathy, which has been confirmed as closely associated with immunity. Whether CKZ is effective against FSGS and how it works warrant further study. This study aimed to verify the efficacy of CKZ in rats with steroid-resistant (SR) FSGS and explore its mechanism of action. METHODS: We established an SR FSGS model in male Sprague Dawley (SD) rats by injecting adriamycin into the tail vein. Based on group intervention and comparison, the primary efficacy parameters of FSGS were observed, including general condition, 24-hour urine protein, serum albumin, cholesterol, triglyceride, and renal pathological changes. Network pharmacological analysis and molecular docking were used to predict the mechanism of action of CKZ. Finally, we used quantitative polymerase chain reaction (qPCR) and western blot (WB) to detect messenger RNA (mRNA) expression and protein phosphorylation at specific targets in rat kidney tissue to validate the predicted results. RESULTS: Intramuscular injection of CKZ had a dose-dependent effect in SR FSGS model rats, including lowering urine protein, increasing serum albumin, lowering cholesterol and triglyceride, and treating pathological lesions in the kidney. Network pharmacological analysis and Molecular docking revealed that 5 active components (Icariin, Icariside II, Epimedin C, Icaritin, and Noricaritin) might be the critical components. The findings also revealed that Akt was perhaps the critical target gene, the PI3K-Akt signaling pathway was perhaps the critical pathway, and reversible protein phosphorylation was probably the critical biological process. The qPCR and WB analyses showed that CKZ significantly increased the relative mRNA expression and protein phosphorylation of PI3K and Akt, respectively. CONCLUSIONS: This study showed that intramuscular injection of CKZ has a significant therapeutic effect in SR FSGS rats, which may be associated with the activation of PI3K-Akt signaling by CKZ.
format Online
Article
Text
id pubmed-9263774
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-92637742022-07-09 New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action Liang, Rui Yang, Xiang-Na Lin, Shan Yi, Wei-Qing Chen, Xiao-Gang Dong, Xin Guo, Long-Gang Li, Yan-Kun Zhao, Yue-Rui Xu, Hua Ann Transl Med Original Article BACKGROUND: Chuankezhi (CKZ) injection is a traditional Chinese medicine (TCM) injection extracted from Chinese herbs Epimedium sagittatum (Yin Yang Huo) and Morinda officinalis (Bai Ji Tian). Studies have shown that CKZ has a positive effect on improving diabetic nephropathy and regulating immune function. Focal segmental glomerulosclerosis (FSGS) is a kind of refractory nephropathy, which has been confirmed as closely associated with immunity. Whether CKZ is effective against FSGS and how it works warrant further study. This study aimed to verify the efficacy of CKZ in rats with steroid-resistant (SR) FSGS and explore its mechanism of action. METHODS: We established an SR FSGS model in male Sprague Dawley (SD) rats by injecting adriamycin into the tail vein. Based on group intervention and comparison, the primary efficacy parameters of FSGS were observed, including general condition, 24-hour urine protein, serum albumin, cholesterol, triglyceride, and renal pathological changes. Network pharmacological analysis and molecular docking were used to predict the mechanism of action of CKZ. Finally, we used quantitative polymerase chain reaction (qPCR) and western blot (WB) to detect messenger RNA (mRNA) expression and protein phosphorylation at specific targets in rat kidney tissue to validate the predicted results. RESULTS: Intramuscular injection of CKZ had a dose-dependent effect in SR FSGS model rats, including lowering urine protein, increasing serum albumin, lowering cholesterol and triglyceride, and treating pathological lesions in the kidney. Network pharmacological analysis and Molecular docking revealed that 5 active components (Icariin, Icariside II, Epimedin C, Icaritin, and Noricaritin) might be the critical components. The findings also revealed that Akt was perhaps the critical target gene, the PI3K-Akt signaling pathway was perhaps the critical pathway, and reversible protein phosphorylation was probably the critical biological process. The qPCR and WB analyses showed that CKZ significantly increased the relative mRNA expression and protein phosphorylation of PI3K and Akt, respectively. CONCLUSIONS: This study showed that intramuscular injection of CKZ has a significant therapeutic effect in SR FSGS rats, which may be associated with the activation of PI3K-Akt signaling by CKZ. AME Publishing Company 2022-06 /pmc/articles/PMC9263774/ /pubmed/35813313 http://dx.doi.org/10.21037/atm-22-1962 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Liang, Rui
Yang, Xiang-Na
Lin, Shan
Yi, Wei-Qing
Chen, Xiao-Gang
Dong, Xin
Guo, Long-Gang
Li, Yan-Kun
Zhao, Yue-Rui
Xu, Hua
New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title_full New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title_fullStr New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title_full_unstemmed New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title_short New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
title_sort new indication of chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263774/
https://www.ncbi.nlm.nih.gov/pubmed/35813313
http://dx.doi.org/10.21037/atm-22-1962
work_keys_str_mv AT liangrui newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT yangxiangna newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT linshan newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT yiweiqing newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT chenxiaogang newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT dongxin newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT guolonggang newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT liyankun newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT zhaoyuerui newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction
AT xuhua newindicationofchuankezhiinjectionforsteroidresistantfocalsegmentalglomerulosclerosisanditsmechanismofaction